Genetic Deletion of Glycogen Synthase Kinase-3β Abrogates Activation of IκBα Kinase, JNK, Akt, and p44/p42 MAPK but Potentiates Apoptosis Induced by Tumor Necrosis Factor
Open Access
- 1 September 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (38), 39541-39554
- https://doi.org/10.1074/jbc.m403449200
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Alleviating the Suppression of Glycogen Synthase Kinase-3β by Akt Leads to the Phosphorylation of cAMP-response Element-binding Protein and Its Transactivation in Intact Cell NucleiPublished by Elsevier ,2003
- Regulation of Angiogenesis by Glycogen Synthase Kinase-3βPublished by Elsevier ,2002
- Nuclear transcription factor-κB as a target for cancer drug developmentLeukemia, 2002
- GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activityFEBS Letters, 2001
- Activation of glycogen synthase kinase 3 beta (GSK‐3β) by platelet activating factor mediates migration and cell death in cerebellar granule neuronsEuropean Journal of Neuroscience, 2001
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐cateninFEBS Letters, 1999
- Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3βCurrent Biology, 1998
- MEKK1 Binds Directly to the c-Jun N-terminal Kinases/Stress-activated Protein KinasesPublished by Elsevier ,1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996